UpdatesGeneral Updates
Saroja Pharma reports strong FY25, with revenue climbing to ₹53.73 Cr and PAT reaching ₹1.03 Cr.
Saroja Pharma Industries India LimitedSAROJA · Filed with the exchange
Shareholders will consider appointing Ms. Anita Sethia as Independent Director.
Auditors noted issues verifying accounting software's audit trail.
No dividend was declared.
No comments yet. Be the first.